context
stringlengths
21
33.9k
category
stringclasses
2 values
entity
stringlengths
1
12
entity_type
stringclasses
5 values
query
stringlengths
97
3.31k
answer
stringlengths
12
169
The Company had several defined benefit pension plans in locations outside of the United States. The total projected benefit obligation, assets and unfunded liability for these plans as of year-end 2023 were $ 9.7 million, $ 8.0 million and $ 1.7 million, respectively, all of which were included as held for sale (see ...
text
0.2
monetaryItemType
text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company had several defined benefit pension plans in locations outside of the United States. The total projected benefit obligation, assets and unfunded liability for these plans as of year-end 2023 were $ 9.7 million, $ 8.0 milli...
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
The Company had several defined benefit pension plans in locations outside of the United States. The total projected benefit obligation, assets and unfunded liability for these plans as of year-end 2023 were $ 9.7 million, $ 8.0 million and $ 1.7 million, respectively, all of which were included as held for sale (see ...
text
0.4
monetaryItemType
text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company had several defined benefit pension plans in locations outside of the United States. The total projected benefit obligation, assets and unfunded liability for these plans as of year-end 2023 were $ 9.7 million, $ 8.0 milli...
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
The authorized capital stock of the Company is 100,000,000 shares of Class A common stock and 10,000,000 shares of Class B common stock. Class A shares have no voting rights and are not convertible. Class B shares have voting rights and are convertible by the holder into Class A shares on a share-for-share basis at an...
text
100000000
sharesItemType
text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> The authorized capital stock of the Company is 100,000,000 shares of Class A common stock and 10,000,000 shares of Class B common stock. Class A shares have no voting rights and are not convertible. Class B shares have voting righ...
us-gaap:CommonStockSharesAuthorized
The authorized capital stock of the Company is 100,000,000 shares of Class A common stock and 10,000,000 shares of Class B common stock. Class A shares have no voting rights and are not convertible. Class B shares have voting rights and are convertible by the holder into Class A shares on a share-for-share basis at an...
text
10000000
sharesItemType
text: <entity> 10000000 </entity> <entity type> sharesItemType </entity type> <context> The authorized capital stock of the Company is 100,000,000 shares of Class A common stock and 10,000,000 shares of Class B common stock. Class A shares have no voting rights and are not convertible. Class B shares have voting right...
us-gaap:CommonStockSharesAuthorized
In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million at an average price of $ 13.49 per share. A total of $ 40.0 million remains availabl...
text
742163
sharesItemType
text: <entity> 742163 </entity> <entity type> sharesItemType </entity type> <context> In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million...
us-gaap:TreasuryStockSharesAcquired
In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million at an average price of $ 13.49 per share. A total of $ 40.0 million remains availabl...
text
10.0
monetaryItemType
text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million...
us-gaap:PaymentsForRepurchaseOfCommonStock
In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million at an average price of $ 13.49 per share. A total of $ 40.0 million remains availabl...
text
13.49
perShareItemType
text: <entity> 13.49 </entity> <entity type> perShareItemType </entity type> <context> In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 millio...
us-gaap:TreasuryStockAcquiredAverageCostPerShare
In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million at an average price of $ 13.49 per share. A total of $ 40.0 million remains availabl...
text
40.0
monetaryItemType
text: <entity> 40.0 </entity> <entity type> monetaryItemType </entity type> <context> In November 2024, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program that expires on December 2, 2026. During December 2024, the Company repurchased 742,163 Class A shares for $ 10.0 million...
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
2496827
sharesItemType
text: <entity> 2496827 </entity> <entity type> sharesItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 m...
us-gaap:TreasuryStockSharesAcquired
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
42.2
monetaryItemType
text: <entity> 42.2 </entity> <entity type> monetaryItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 mi...
us-gaap:PaymentsForRepurchaseOfCommonStock
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
474644
sharesItemType
text: <entity> 474644 </entity> <entity type> sharesItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 mi...
us-gaap:TreasuryStockSharesAcquired
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
7.8
monetaryItemType
text: <entity> 7.8 </entity> <entity type> monetaryItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 mil...
us-gaap:PaymentsForRepurchaseOfCommonStock
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
no
monetaryItemType
text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 mill...
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
42.2
monetaryItemType
text: <entity> 42.2 </entity> <entity type> monetaryItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 mi...
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
2971471
sharesItemType
text: <entity> 2971471 </entity> <entity type> sharesItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 m...
us-gaap:TreasuryStockSharesAcquired
In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 million and 474,644 Class A shares for $ 7.8 million, respectively. There were no remai...
text
16.83
perShareItemType
text: <entity> 16.83 </entity> <entity type> perShareItemType </entity type> <context> In November 2022, the Company's board of directors authorized a $ 50.0 million Class A share repurchase program, which was completed in August 2023. During 2023 and 2022, the Company repurchased 2,496,827 Class A shares for $ 42.2 m...
us-gaap:TreasuryStockAcquiredAverageCostPerShare
Of the amount included in this line item $ 1.9 million in 2022 was recorded in the other income (expense), net line item in the consolidated statements of earnings related to the investment in PersolKelly Pte. Ltd. (see Investment in PersolKelly Pte. Ltd. footnote for more details). In addition, $ 1.4 million in 2022 ...
text
1.9
monetaryItemType
text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> Of the amount included in this line item $ 1.9 million in 2022 was recorded in the other income (expense), net line item in the consolidated statements of earnings related to the investment in PersolKelly Pte. Ltd. (see Investment in P...
us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
Of the amount included in this line item $ 1.9 million in 2022 was recorded in the other income (expense), net line item in the consolidated statements of earnings related to the investment in PersolKelly Pte. Ltd. (see Investment in PersolKelly Pte. Ltd. footnote for more details). In addition, $ 1.4 million in 2022 ...
text
1.4
monetaryItemType
text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> Of the amount included in this line item $ 1.9 million in 2022 was recorded in the other income (expense), net line item in the consolidated statements of earnings related to the investment in PersolKelly Pte. Ltd. (see Investment in P...
us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
Due to our net loss in 2024, potentially dilutive shares outstanding, primarily related to deferred common stock associated with the non-employee directors deferred compensation plan and performance shares, of 0.4 million shares in 2024, had an anti-dilutive effect on diluted earnings per share and were excluded from t...
text
0.4
sharesItemType
text: <entity> 0.4 </entity> <entity type> sharesItemType </entity type> <context> Due to our net loss in 2024, potentially dilutive shares outstanding, primarily related to deferred common stock associated with the non-employee directors deferred compensation plan and performance shares, of 0.4 million shares in 2024,...
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Due to our net loss in 2024, potentially dilutive shares outstanding, primarily related to deferred common stock associated with the non-employee directors deferred compensation plan and performance shares, of 0.4 million shares in 2024, had an anti-dilutive effect on diluted earnings per share and were excluded from t...
text
0.2
sharesItemType
text: <entity> 0.2 </entity> <entity type> sharesItemType </entity type> <context> Due to our net loss in 2024, potentially dilutive shares outstanding, primarily related to deferred common stock associated with the non-employee directors deferred compensation plan and performance shares, of 0.4 million shares in 2024,...
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Under the Equity Incentive Plan, amended and restated February 15, 2017 and approved by the stockholders of the Company on May 10, 2017 (the “EIP”), the Company may grant to key employees restricted stock and performance awards associated with the Company’s Class A stock. The amended EIP provides that the maximum numb...
text
4.7
sharesItemType
text: <entity> 4.7 </entity> <entity type> sharesItemType </entity type> <context> Under the Equity Incentive Plan, amended and restated February 15, 2017 and approved by the stockholders of the Company on May 10, 2017 (the “EIP”), the Company may grant to key employees restricted stock and performance awards associate...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
Under the Equity Incentive Plan, amended and restated February 15, 2017 and approved by the stockholders of the Company on May 10, 2017 (the “EIP”), the Company may grant to key employees restricted stock and performance awards associated with the Company’s Class A stock. The amended EIP provides that the maximum numb...
text
1.3
sharesItemType
text: <entity> 1.3 </entity> <entity type> sharesItemType </entity type> <context> Under the Equity Incentive Plan, amended and restated February 15, 2017 and approved by the stockholders of the Company on May 10, 2017 (the “EIP”), the Company may grant to key employees restricted stock and performance awards associate...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022.
text
11.8
monetaryItemType
text: <entity> 11.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022...
us-gaap:AllocatedShareBasedCompensationExpense
The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022.
text
9.7
monetaryItemType
text: <entity> 9.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022....
us-gaap:AllocatedShareBasedCompensationExpense
The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022.
text
7.8
monetaryItemType
text: <entity> 7.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022....
us-gaap:AllocatedShareBasedCompensationExpense
The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022.
text
2.6
monetaryItemType
text: <entity> 2.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022....
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022.
text
1.7
monetaryItemType
text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022....
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022.
text
1.1
monetaryItemType
text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation cost of $ 11.8 million in 2024, $ 9.7 million in 2023 and $ 7.8 million in 2022, as well as related tax benefits of $ 2.6 million in 2024, $ 1.7 million in 2023 and $ 1.1 million in 2022....
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
14.5
monetaryItemType
text: <entity> 14.5 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted ...
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
20.70
perShareItemType
text: <entity> 20.70 </entity> <entity type> perShareItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
17.33
perShareItemType
text: <entity> 17.33 </entity> <entity type> perShareItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
20.16
perShareItemType
text: <entity> 20.16 </entity> <entity type> perShareItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
6.5
monetaryItemType
text: <entity> 6.5 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted a...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
3.3
monetaryItemType
text: <entity> 3.3 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted a...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted average grant date fair value per share of restricted stock granted during 2024, 2023 ...
text
2.3
monetaryItemType
text: <entity> 2.3 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to unvested restricted stock totaled $ 14.5 million. The weighted average period over which this cost is expected to be recognized is approximately 1.3 years. The weighted a...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
During 2024, 2023 and 2022, the Company granted performance awards associated with the Company’s Class A stock to certain senior officers, which are contingent upon achievement of specific revenue growth and EBITDA margin performance goals over a stated period of time ("performance awards"). The maximum number of perf...
text
200
percentItemType
text: <entity> 200 </entity> <entity type> percentItemType </entity type> <context> During 2024, 2023 and 2022, the Company granted performance awards associated with the Company’s Class A stock to certain senior officers, which are contingent upon achievement of specific revenue growth and EBITDA margin performance go...
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
The 2024, 2023 and 2022 performance awards have a weighted average grant date fair value of $ 19.96 , $ 16.87 and $ 19.07 , respectively, which was determined by the market price on the date of grant less the present value of the expected dividends not received during the vesting period.
text
19.96
perShareItemType
text: <entity> 19.96 </entity> <entity type> perShareItemType </entity type> <context> The 2024, 2023 and 2022 performance awards have a weighted average grant date fair value of $ 19.96 , $ 16.87 and $ 19.07 , respectively, which was determined by the market price on the date of grant less the present value of the exp...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
The 2024, 2023 and 2022 performance awards have a weighted average grant date fair value of $ 19.96 , $ 16.87 and $ 19.07 , respectively, which was determined by the market price on the date of grant less the present value of the expected dividends not received during the vesting period.
text
16.87
perShareItemType
text: <entity> 16.87 </entity> <entity type> perShareItemType </entity type> <context> The 2024, 2023 and 2022 performance awards have a weighted average grant date fair value of $ 19.96 , $ 16.87 and $ 19.07 , respectively, which was determined by the market price on the date of grant less the present value of the exp...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
The 2024, 2023 and 2022 performance awards have a weighted average grant date fair value of $ 19.96 , $ 16.87 and $ 19.07 , respectively, which was determined by the market price on the date of grant less the present value of the expected dividends not received during the vesting period.
text
19.07
perShareItemType
text: <entity> 19.07 </entity> <entity type> perShareItemType </entity type> <context> The 2024, 2023 and 2022 performance awards have a weighted average grant date fair value of $ 19.96 , $ 16.87 and $ 19.07 , respectively, which was determined by the market price on the date of grant less the present value of the exp...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
The total nonvested shares related to 2024, 2023 and 2022 performance awards at year-end 2024 is 170,000 , 211,000 and 165,000 , respectively.
text
170000
sharesItemType
text: <entity> 170000 </entity> <entity type> sharesItemType </entity type> <context> The total nonvested shares related to 2024, 2023 and 2022 performance awards at year-end 2024 is 170,000 , 211,000 and 165,000 , respectively. </context>
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
The total nonvested shares related to 2024, 2023 and 2022 performance awards at year-end 2024 is 170,000 , 211,000 and 165,000 , respectively.
text
211000
sharesItemType
text: <entity> 211000 </entity> <entity type> sharesItemType </entity type> <context> The total nonvested shares related to 2024, 2023 and 2022 performance awards at year-end 2024 is 170,000 , 211,000 and 165,000 , respectively. </context>
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
The total nonvested shares related to 2024, 2023 and 2022 performance awards at year-end 2024 is 170,000 , 211,000 and 165,000 , respectively.
text
165000
sharesItemType
text: <entity> 165000 </entity> <entity type> sharesItemType </entity type> <context> The total nonvested shares related to 2024, 2023 and 2022 performance awards at year-end 2024 is 170,000 , 211,000 and 165,000 , respectively. </context>
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
In December 2020, the Company granted 115,000 performance shares to certain senior officers, which were contingent upon the achievement of a specific operating earnings performance goal with a one-year performance period. These performance shares vest over four years and earn dividends, which are not paid until the aw...
text
115000
sharesItemType
text: <entity> 115000 </entity> <entity type> sharesItemType </entity type> <context> In December 2020, the Company granted 115,000 performance shares to certain senior officers, which were contingent upon the achievement of a specific operating earnings performance goal with a one-year performance period. These perfo...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
In December 2020, the Company granted 115,000 performance shares to certain senior officers, which were contingent upon the achievement of a specific operating earnings performance goal with a one-year performance period. These performance shares vest over four years and earn dividends, which are not paid until the aw...
text
22.59
perShareItemType
text: <entity> 22.59 </entity> <entity type> perShareItemType </entity type> <context> In December 2020, the Company granted 115,000 performance shares to certain senior officers, which were contingent upon the achievement of a specific operating earnings performance goal with a one-year performance period. These perf...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
In December 2020, the Company granted 115,000 performance shares to certain senior officers, which were contingent upon the achievement of a specific operating earnings performance goal with a one-year performance period. These performance shares vest over four years and earn dividends, which are not paid until the aw...
text
22000
sharesItemType
text: <entity> 22000 </entity> <entity type> sharesItemType </entity type> <context> In December 2020, the Company granted 115,000 performance shares to certain senior officers, which were contingent upon the achievement of a specific operating earnings performance goal with a one-year performance period. These perfor...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for performance shares. The total fair value of performance shares, which vested during 2024, ...
text
3.4
monetaryItemType
text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for perfor...
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for performance shares. The total fair value of performance shares, which vested during 2024, ...
text
2.6
monetaryItemType
text: <entity> 2.6 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for perfor...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for performance shares. The total fair value of performance shares, which vested during 2024, ...
text
3.4
monetaryItemType
text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for perfor...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for performance shares. The total fair value of performance shares, which vested during 2024, ...
text
0.9
monetaryItemType
text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, unrecognized compensation cost related to all unvested performance shares totaled $ 3.4 million. The weighted average period over which the costs are expected to be recognized is approximately 1.3 years for perfor...
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2024 for assets sold with a net carrying value of $ 1.0 million. In the third quarter...
text
7.5
monetaryItemType
text: <entity> 7.5 </entity> <entity type> monetaryItemType </entity type> <context> On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2...
us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2024 for assets sold with a net carrying value of $ 1.0 million. In the third quarter...
text
4.5
monetaryItemType
text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2...
us-gaap:ProceedsFromSaleOfOtherProductiveAssets
On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2024 for assets sold with a net carrying value of $ 1.0 million. In the third quarter...
text
1.0
monetaryItemType
text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2...
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2024 for assets sold with a net carrying value of $ 1.0 million. In the third quarter...
text
0.1
monetaryItemType
text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2...
us-gaap:GainLossOnDispositionOfAssets1
On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2024 for assets sold with a net carrying value of $ 1.0 million. In the third quarter...
text
5.4
monetaryItemType
text: <entity> 5.4 </entity> <entity type> monetaryItemType </entity type> <context> On June 10, 2024, the Company sold Ayers Group, a division of our OCG segment, for a purchase price of $ 7.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 4.5 million in the second quarter of 2...
us-gaap:GainLossOnDispositionOfAssets1
In October 2022, Kelly Properties, LLC, a wholly owned subsidiary of the Company, sold real property located in Troy, Michigan for a purchase price of $ 6.0 million, subject to final closing adjustments. The Company received cash proceeds of $ 5.6 million in the fourth quarter of 2022, net of commissions and transacti...
text
5.6
monetaryItemType
text: <entity> 5.6 </entity> <entity type> monetaryItemType </entity type> <context> In October 2022, Kelly Properties, LLC, a wholly owned subsidiary of the Company, sold real property located in Troy, Michigan for a purchase price of $ 6.0 million, subject to final closing adjustments. The Company received cash proc...
us-gaap:ProceedsFromSaleOfPropertyHeldForSale
had a carrying value of $ 4.7 million, resulting in a $ 0.9 million gain on the sale, which was recorded in gain on sale of assets in the consolidated statements of earnings.
text
4.7
monetaryItemType
text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> had a carrying value of $ 4.7 million, resulting in a $ 0.9 million gain on the sale, which was recorded in gain on sale of assets in the consolidated statements of earnings. </context>
us-gaap:RealEstateHeldforsale
had a carrying value of $ 4.7 million, resulting in a $ 0.9 million gain on the sale, which was recorded in gain on sale of assets in the consolidated statements of earnings.
text
0.9
monetaryItemType
text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> had a carrying value of $ 4.7 million, resulting in a $ 0.9 million gain on the sale, which was recorded in gain on sale of assets in the consolidated statements of earnings. </context>
us-gaap:GainLossOnSaleOfProperties
In June 2022, the Company sold an under-utilized real property for a purchase price of $ 4.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 3.6 million in the second quarter of 2022 and previously received cash proceeds of $ 0.8 million as a deposit in 2021 when the contract was ...
text
3.6
monetaryItemType
text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> In June 2022, the Company sold an under-utilized real property for a purchase price of $ 4.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 3.6 million in the second quarter of 2022 and previousl...
us-gaap:ProceedsFromSaleOfLandHeldforinvestment
In June 2022, the Company sold an under-utilized real property for a purchase price of $ 4.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 3.6 million in the second quarter of 2022 and previously received cash proceeds of $ 0.8 million as a deposit in 2021 when the contract was ...
text
0.8
monetaryItemType
text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> In June 2022, the Company sold an under-utilized real property for a purchase price of $ 4.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 3.6 million in the second quarter of 2022 and previousl...
us-gaap:ProceedsFromSaleOfLandHeldforinvestment
In June 2022, the Company sold an under-utilized real property for a purchase price of $ 4.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 3.6 million in the second quarter of 2022 and previously received cash proceeds of $ 0.8 million as a deposit in 2021 when the contract was ...
text
4.4
monetaryItemType
text: <entity> 4.4 </entity> <entity type> monetaryItemType </entity type> <context> In June 2022, the Company sold an under-utilized real property for a purchase price of $ 4.5 million, subject to final closing adjustments. The Company received cash proceeds of $ 3.6 million in the second quarter of 2022 and previousl...
us-gaap:GainLossOnSaleOfProperties
In January 2022, the Company sold a property for a purchase price of $ 0.9 million, subject to final closing adjustments. The Company received cash proceeds of $ 0.9 million in the first quarter of 2022. As of the date of the sale, the property had an immaterial carrying value; as such, the resulting gain on the sale o...
text
0.9
monetaryItemType
text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> In January 2022, the Company sold a property for a purchase price of $ 0.9 million, subject to final closing adjustments. The Company received cash proceeds of $ 0.9 million in the first quarter of 2022. As of the date of the sale, the...
us-gaap:ProceedsFromSaleOfPropertyHeldForSale
In January 2022, the Company sold a property for a purchase price of $ 0.9 million, subject to final closing adjustments. The Company received cash proceeds of $ 0.9 million in the first quarter of 2022. As of the date of the sale, the property had an immaterial carrying value; as such, the resulting gain on the sale o...
text
0.9
monetaryItemType
text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> In January 2022, the Company sold a property for a purchase price of $ 0.9 million, subject to final closing adjustments. The Company received cash proceeds of $ 0.9 million in the first quarter of 2022. As of the date of the sale, the...
us-gaap:GainLossOnSaleOfProperties
As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 million with $ 321.1 million in deferred taxes, $ 4.1 million in assets held for sale (see...
text
330.1
monetaryItemType
text: <entity> 330.1 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 mil...
us-gaap:DeferredTaxAssetsLiabilitiesNet
As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 million with $ 321.1 million in deferred taxes, $ 4.1 million in assets held for sale (see...
text
324.8
monetaryItemType
text: <entity> 324.8 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 mil...
us-gaap:DeferredTaxAssetsLiabilitiesNet
As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 million with $ 321.1 million in deferred taxes, $ 4.1 million in assets held for sale (see...
text
321.1
monetaryItemType
text: <entity> 321.1 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 mil...
us-gaap:DeferredTaxAssetsLiabilitiesNet
As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 million with $ 321.1 million in deferred taxes, $ 4.1 million in assets held for sale (see...
text
4.1
monetaryItemType
text: <entity> 4.1 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 milli...
us-gaap:DeferredTaxAssetsLiabilitiesNet
As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 million with $ 321.1 million in deferred taxes, $ 4.1 million in assets held for sale (see...
text
0.4
monetaryItemType
text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> As of year-end 2024, the net deferred tax asset balance totaled $ 330.1 million which is fully recorded in deferred taxes in the consolidated balance sheet. As of year-end 2023, the net deferred tax asset balance totaled $ 324.8 milli...
us-gaap:DeferredTaxAssetsLiabilitiesNet
The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign credit carryforwards which are either indefinite or will expire from 2025 to 2043. The ...
text
197.3
monetaryItemType
text: <entity> 197.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign c...
us-gaap:TaxCreditCarryforwardAmount
The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign credit carryforwards which are either indefinite or will expire from 2025 to 2043. The ...
text
33.2
monetaryItemType
text: <entity> 33.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign cr...
us-gaap:TaxCreditCarryforwardAmount
The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign credit carryforwards which are either indefinite or will expire from 2025 to 2043. The ...
text
30.5
monetaryItemType
text: <entity> 30.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign cr...
us-gaap:OperatingLossCarryforwards
The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign credit carryforwards which are either indefinite or will expire from 2025 to 2043. The ...
text
19.6
monetaryItemType
text: <entity> 19.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company has U.S. general business credit carryforwards of $ 197.3 million which will expire from 2034 to 2044, foreign tax credit carryforwards of $ 33.2 million which will expire from 2026 to 2034 and minimal state and foreign cr...
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
2029, and $ 10.9 million of net operating loss carryforwards of which $ 9.1 million have no expiration and $ 1.8 million expire between 2025 and 2044.
text
10.9
monetaryItemType
text: <entity> 10.9 </entity> <entity type> monetaryItemType </entity type> <context> 2029, and $ 10.9 million of net operating loss carryforwards of which $ 9.1 million have no expiration and $ 1.8 million expire between 2025 and 2044. </context>
us-gaap:OperatingLossCarryforwards
2029, and $ 10.9 million of net operating loss carryforwards of which $ 9.1 million have no expiration and $ 1.8 million expire between 2025 and 2044.
text
9.1
monetaryItemType
text: <entity> 9.1 </entity> <entity type> monetaryItemType </entity type> <context> 2029, and $ 10.9 million of net operating loss carryforwards of which $ 9.1 million have no expiration and $ 1.8 million expire between 2025 and 2044. </context>
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
2029, and $ 10.9 million of net operating loss carryforwards of which $ 9.1 million have no expiration and $ 1.8 million expire between 2025 and 2044.
text
1.8
monetaryItemType
text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> 2029, and $ 10.9 million of net operating loss carryforwards of which $ 9.1 million have no expiration and $ 1.8 million expire between 2025 and 2044. </context>
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance during 2024 was primarily due to the Company’s sale of its EMEA staffing operations w...
text
24.4
monetaryItemType
text: <entity> 24.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance...
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance during 2024 was primarily due to the Company’s sale of its EMEA staffing operations w...
text
19.6
monetaryItemType
text: <entity> 19.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance...
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance during 2024 was primarily due to the Company’s sale of its EMEA staffing operations w...
text
21.4
monetaryItemType
text: <entity> 21.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance...
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance during 2024 was primarily due to the Company’s sale of its EMEA staffing operations w...
text
19.2
monetaryItemType
text: <entity> 19.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance...
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance during 2024 was primarily due to the Company’s sale of its EMEA staffing operations w...
text
15.0
monetaryItemType
text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance...
us-gaap:DeferredTaxAssetsValuationAllowance
The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance during 2024 was primarily due to the Company’s sale of its EMEA staffing operations w...
text
14.5
monetaryItemType
text: <entity> 14.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company has established a valuation allowance for certain loss carryforwards, future deductible items, outside basis differences, and for a portion of its U.S. foreign tax credit carryforwards. The decrease in valuation allowance...
us-gaap:DeferredTaxAssetsValuationAllowance
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
18.5
monetaryItemType
text: <entity> 18.5 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 1...
us-gaap:IncomeTaxExpenseBenefit
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
6.2
monetaryItemType
text: <entity> 6.2 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15...
us-gaap:CashSurrenderValueOfLifeInsurance
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
15.0
monetaryItemType
text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 1...
us-gaap:IncomeTaxExpenseBenefit
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
6.5
monetaryItemType
text: <entity> 6.5 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15...
us-gaap:CashSurrenderValueOfLifeInsurance
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
16.9
monetaryItemType
text: <entity> 16.9 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 1...
us-gaap:IncomeTaxExpenseBenefit
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
7.1
monetaryItemType
text: <entity> 7.1 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15...
us-gaap:IncomeTaxExpenseBenefit
lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15.0 million federal and state benefit on the outside basis difference in held for sale...
text
7.8
monetaryItemType
text: <entity> 7.8 </entity> <entity type> monetaryItemType </entity type> <context> lower pretax earnings, which included an $ 18.5 million benefit from the impairment of tax-deductible goodwill and a $ 6.2 million benefit from tax-exempt life insurance cash surrender value gains. 2023 benefited from recording a $ 15...
us-gaap:CashSurrenderValueOfLifeInsurance
Provision has not been made for additional income taxes on an estimated $ 65.6 million of foreign subsidiary undistributed earnings which are indefinitely reinvested. If these earnings were to be repatriated, the Company could be subject to foreign withholding tax, federal and state income tax, net of federal benefit,...
text
65.6
monetaryItemType
text: <entity> 65.6 </entity> <entity type> monetaryItemType </entity type> <context> Provision has not been made for additional income taxes on an estimated $ 65.6 million of foreign subsidiary undistributed earnings which are indefinitely reinvested. If these earnings were to be repatriated, the Company could be sub...
us-gaap:UndistributedEarningsOfForeignSubsidiaries
Provision has not been made for additional income taxes on an estimated $ 65.6 million of foreign subsidiary undistributed earnings which are indefinitely reinvested. If these earnings were to be repatriated, the Company could be subject to foreign withholding tax, federal and state income tax, net of federal benefit,...
text
4.7
monetaryItemType
text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> Provision has not been made for additional income taxes on an estimated $ 65.6 million of foreign subsidiary undistributed earnings which are indefinitely reinvested. If these earnings were to be repatriated, the Company could be subj...
us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings
If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on income tax expense.
text
0.5
monetaryItemType
text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on...
us-gaap:UnrecognizedTaxBenefits
If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on income tax expense.
text
0.6
monetaryItemType
text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on...
us-gaap:UnrecognizedTaxBenefits
If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on income tax expense.
text
0.4
monetaryItemType
text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on...
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on income tax expense.
text
0.5
monetaryItemType
text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> If the $ 0.5 million in 2024, $ 0.6 million in 2023 and $ 0.5 million in 2022 of unrecognized tax benefits were recognized, they would have a favorable effect of $ 0.4 million in 2024, $ 0.5 million in 2023 and $ 0.4 million in 2022 on...
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
The Company recognizes both interest and penalties as part of the income tax provision. The Company recognized an insignificant benefit in 2024 and $ 0.1 million of expense in 2023, for interest and penalties. The benefit recognized in 2022 was not significant. Accrued interest and penalties were $ 0.2 million at ye...
text
0.1
monetaryItemType
text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognizes both interest and penalties as part of the income tax provision. The Company recognized an insignificant benefit in 2024 and $ 0.1 million of expense in 2023, for interest and penalties. The benefit recognized ...
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
The Company recognizes both interest and penalties as part of the income tax provision. The Company recognized an insignificant benefit in 2024 and $ 0.1 million of expense in 2023, for interest and penalties. The benefit recognized in 2022 was not significant. Accrued interest and penalties were $ 0.2 million at ye...
text
0.2
monetaryItemType
text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognizes both interest and penalties as part of the income tax provision. The Company recognized an insignificant benefit in 2024 and $ 0.1 million of expense in 2023, for interest and penalties. The benefit recognized ...
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022.
text
10.0
monetaryItemType
text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022. </context>
us-gaap:InterestPaidNet
The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022.
text
2.8
monetaryItemType
text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022. </context>
us-gaap:InterestPaidNet
The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022.
text
1.3
monetaryItemType
text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022. </context>
us-gaap:InterestPaidNet
The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022.
text
10.9
monetaryItemType
text: <entity> 10.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022. </context>
us-gaap:IncomeTaxesPaidNet
The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022.
text
8.9
monetaryItemType
text: <entity> 8.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company paid interest of $ 10.0 million in 2024, $ 2.8 million in 2023 and $ 1.3 million in 2022. The Company paid income taxes of $ 10.9 million in 2024, $ 8.9 million in 2023 and $ 61.2 million in 2022. </context>
us-gaap:IncomeTaxesPaidNet